Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News FDA approves Agios Pharmaceuticals’ Tibsovo for targeted acute myeloid leukemia treatment The US Food and Drug Administration (FDA) has granted approval to Agios Pharmaceuticals for Tibsovo (ivosidenib), designed for… bypharmanewsdailyJuly 21, 2018